Viromed Medical AG (ETR:VME)
Germany · Delayed Price · Currency is EUR 7.70
-0.05 (-0.65%)
At close: Aug 5, 2026
Viromed Medical AG Market Cap
Viromed Medical AG has a market cap or net worth of €163.63 million as of August 5, 2026. Its market cap has increased by 124.45% in one year.
Market Cap
163.63M
Enterprise Value
163.27M
Revenue
5.09M
Ranking
n/a
PE Ratio
270.68
Stock Price
€7.70
ChartMarket Cap Chart
Since September 2, 2024, Viromed Medical AG's market cap has increased from 43.74M to 163.63M, an increase of 274.09%. That is a compound annual growth rate of 98.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 163.63M | 112.64% |
| Dec 30, 2025 | 76.95M | 53.23% |
| Dec 30, 2024 | 50.22M | 14.81% |
| Sep 2, 2024 | 43.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 61.93B |
| Bayer Aktiengesellschaft | 46.29B |
| Siemens Healthineers AG | 43.53B |
| Fresenius SE & Co. KGaA | 25.22B |
| M1 Kliniken AG | 346.24M |
| Formycon AG | 335.79M |
| Medios AG | 272.99M |
| Stratec SE | 246.16M |